{"id":"NCT00197184","sponsor":"GlaxoSmithKline","briefTitle":"Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared","officialTitle":"Evaluate the Persistence of Immune Response of GSK Biologicals' Twinrix™ Vaccine, Administered According to a 0,6 Month Schedule and a 0,1,6 Month Schedule, in Healthy Children Aged Between 1-11 Years at the Time of First Vaccine Dose","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-11-01","primaryCompletion":"2004-03-10","completion":"2004-03-10","firstPosted":"2005-09-20","resultsPosted":"2009-06-04","lastUpdate":"2018-08-20"},"enrollment":276,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis B","Hepatitis A"],"interventions":[{"type":"BIOLOGICAL","name":"Twinrix™ Adult","otherNames":["Combined hepatitis A and B vaccine"]},{"type":"BIOLOGICAL","name":"Twinrix™ Junior","otherNames":["Combined hepatitis A and B vaccine"]}],"arms":[{"label":"Twinrix Junior","type":"EXPERIMENTAL"},{"label":"Twinrix Adult","type":"ACTIVE_COMPARATOR"}],"summary":"To evaluate the persistence of anti-hepatitis A virus (HAV) and anti-hepatitis B surface antigen (HBs) antibodies up to 2, 3, 4 and 5 years after administration of the first dose of the study vaccine.\n\nThe Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Anti-hepatitis A (HAV) Antibody Concentrations","timeFrame":"Year 2 (Month 24), Year 3 (Month 36), Year 4 (Month 48) and Year 5 (Month 60)","effectByArm":[{"arm":"Twinrix Adult","deltaMin":1122.2,"sd":null},{"arm":"Twinrix Junior","deltaMin":1377.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":7,"countries":["Australia","Belgium","Spain"]},"refs":{"pmids":["20434544"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":139},"commonTop":["Pain at the injection site","Headache","Fatigue","Gastrointestinal disorder","Arthralgia"]}}